arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Inogen Inc

INGN
$5.09 ▼ -0.13 (-2.49%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
58 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
29
Health
Poor
Bearish
auto_awesome

Analytical Summary

Inogen Inc faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $137.7M
Dividend Yield
Revenue Growth 3.0%
Op. Margin -5.4%
ROIC -2.8%
FCF / Share $0.08
Trailing P/E
Price / Book 0.8x
FCF Yield 1.6%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

58-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$95.08M
↑ +3.0%
Net Income Profit after all expenses
$-3.85M
↑ +7.3%
Operating Margin Operating profit as % of sales
-5.4%
↑ +51.1% 16th
FCF / Share Free cash flow per share
$0.08
↑ +132.7%
Long-Term Debt Long-term obligations
$80.00K
↓ -49.7%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
18
Returns
33
Cash Quality
44

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 15 years · 58 quarters